Directorate Change

RNS Number : 7860Z
BB Healthcare Trust PLC
23 September 2020
 

23 September 2020

BB Healthcare Trust plc (the "Company")

LEI: 213800HQ3J3H9YF2UI82

Director Appointment

The Board of BB Healthcare Trust plc are pleased to announce the appointment of Professor Tony Young, OBE, as a Non-Executive Director of the Company with immediate effect.

 

Professor Young will also be appointed as a member of the Audit Committee and Management Engagement Committee following his appointment to the board.

 

Professor Young is a practicing frontline NHS Consultant Urological Surgeon, Director of Medical Innovation at Anglia Ruskin University, President of the Institute of Decontamination Sciences, and National Clinical Director for Innovation for the NHS. He has founded four Med-Tech start-ups and also co-founded the £500m Anglia Ruskin Med-Tech Campus.

 

In 2014, he was appointed as National Clinical Director for Innovation at NHS England, and in February 2016 became the first National Clinical Lead for Innovation. In this role, he provides clinical leadership and support in delivering improved health outcomes in England and drives the uptake of proven innovations across the NHS as well as promoting economic growth through innovation. In 2015, Professor Young founded the NHS Clinical Entrepreneur Programme, which has become the world's largest entrepreneurial workforce development programme for clinicians.

 

Professor Young was previously a member of the Royal College of Surgeon's Commission on the Future of Surgery (2017 - 2018). In the 2019 New Year's Honours list, Professor Young was awarded the OBE for services to clinical leadership.

 

Randeep Grewal, Chairman, commented:

"I am delighted to welcome Professor Young to the Board as a Non-Executive Director. He brings a wealth of experience in medical innovation, which will further strengthen our Board and we look forward to working with him."

 

Antony ("Tony") John Young was a director of Enterprise Medical Limited and Sterile Scopes Limited (a wholly owned subsidiary of Enterprise Medical Ltd) both of which were placed into administration in 2012. There is no further information required to be disclosed pursuant to LR9.6.13R.

 

Enquiries:  

Company Secretary   020 4513 9260

PraxisIFM Fund Services (UK) Limited

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGZLVZVGGZM
UK 100